Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;3(2):202-205.
doi: 10.1007/s13730-014-0118-1. Epub 2014 Mar 21.

Graft versus host disease-dependent renal dysfunction after hematopoietic stem cell transplantation

Affiliations

Graft versus host disease-dependent renal dysfunction after hematopoietic stem cell transplantation

Yaeko Motoyoshi et al. CEN Case Rep. 2014 Nov.

Abstract

Nephropathy is an important complication in hematopoietic stem cell transplantation (HSCT) wherein multifactorial causes, i.e., radiation, drug toxicity, graft versus host disease (GVHD), are thought to contribute renal dysfunction. Here, we report a 10-year-old boy with high-risk acute myelocytic leukemia and severe but partially reversible renal dysfunction. The patient initially received umbilical cord blood transplantation (UCBT) with CY 120 mg/kg and kidney unshielded 12 Gy of total body irradiation. After the leukemic relapse, he received allogenic bone marrow transplantation (BMT) 270 days after the first transplantation. Two months later, his renal function started to deteriorate and urinary protein increased gradually to 1 g/day. Four months after BMT, by the symptoms of severe GVHD, the dose of tacrolimus, utilized to avoid GVHD, was increased although his serum Cre level elevated to 2.97 mg/dL. Serum Cre level improved to 2.0 mg/dL paralleled with GVHD improvement. Renal histological findings showed severe interstitial edema, features of thrombotic microangiopathy (TMA), and C4d deposition along the glomerular capillaries and peritubular capillaries. We suggested that control of GVHD had benefitted to ameliorate renal function of the patient. Treatment for GVHD improved renal dysfunction and TMA of our patients. Moreover, renal biopsy was powerful to elucidate the exact origin of renal dysfunction after HSCT.

Keywords: Bone marrow transplant nephropathy; Calcineurin inhibitor nephrotoxicity; Interstitial edema; Mesangiolysis; Thrombotic microangiopathy; Total body irradiation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Clinical course after bone marrow transplantation. Serum creatinine level of our patient ascended gradually after infectious events. Because of renal dysfunction, tacrolimus dose was reduced gradually from 1 mg per day to 0.1 mg per day. After GVHD became obvious, tacrolimus dose was increased to 0.5 mg per day which was effective for renal function recovery
Fig. 2
Fig. 2
Renal histological findings of the patient 8 months after second HSCT. a Diffuse fibrosis, edema and infiltration of lymphocytes are observed in interstitial area in Masson’s Trichrome staining. Diffuse interstitial fibrosis is accompanied by lymphoid cells infiltration. Note glomeruli are diffusely collapsed with widening of urinary space. b Slightly thickened wall of arteriole is observed in Periodic acid-Schiff staining. c Segmental mesangiolysis is notable and double contour in glomerular basement membrane. Periodic acid methenamine silver staining d. C4d deposition was detected along the glomerular capillaries and peritubular capillaries

Similar articles

Cited by

References

    1. Sakai K, Usui J, Kai H, Hagiwara M, Morito N, Saito C, Yoh K, Tsuruoka W, Hirayama K, Aita K, Nagata M, Yamagata K. Secondary membranous glomerulonephritis associated with recipient residual lymphoma cells after allogeneic bone marrow transplantation. Clin Exp Nephrol. 2009;13:174–178. doi: 10.1007/s10157-008-0120-z. - DOI - PubMed
    1. Hazar V, Gungor O, Guven AG, Aydin F, Akbas H, Gungor F, Tezcan G, Akman S, Yesilipek A. Renal function after hematopoietic stem cell transplantation in children. Pediatr Blood Cancer. 2009;53:197–202. doi: 10.1002/pbc.22030. - DOI - PubMed
    1. Batts ED, Lazarus HM. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant. 2007;40:709–719. doi: 10.1038/sj.bmt.1705758. - DOI - PubMed
    1. Singh N, McNeely J, Parikh S, Bhinder A, Rovin BH, Shidham G. Kidney complications of hematopoietic stem cell transplantation. Am J Kidney Dis. 2013;61(5):809–821. doi: 10.1053/j.ajkd.2012.09.020. - DOI - PubMed
    1. Cilley J, Winter JN. Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomas. Haematologica. 2006;91:113–120. - PubMed

LinkOut - more resources